FDA Orange Book Milestone: First-Ever Liquid Losartan Secures Patent Protection Until 2041

SCIENTURE announces FDA Orange Book Patent Listing for ArbliTM, (losartanpotassium) Oral Suspension, 10mg/mL. Rhea-AI Impact.